MENLO PARK, Calif.--(BUSINESS WIRE)-- GRAIL, LLC, a healthcare company whose mission is to detect cancer early when it can be cured, today presented analytical validation data on its recently launched ...
-Only MCED test to use a urine sample collected at home instead of blood draw. -Only MCED to detect stage I/II cancers with 97% sensitivity and 97% specificity. -Offered as a laboratory-developed test ...
In a recent study published on the preprint server medRxiv*, researchers analyze commercially available rapid antigen tests to evaluate their analytical sensitivity and specificity, as well as ...
Blood tests can be useful to detect cancer. But they have limitations: they may only be useful for a single cancer or require tumor tissue. The Menlo Park-based company GRAIL has developed a ...
The fraction, volume and frequency of the patient sample collection; DNA extraction and purification procedures, which greatly influence the performance of the downstream molecular tests. It is worth ...
As next-generation sequencing (NGS) makes genetic testing for a wide range of human diseases increasingly commonplace, facile methods for validating the efficacy of those tests are essential. Federal ...
Which is more important when working with healthcare AI detection: that it never misses something on a patient scan, or that it never identifies something that isn’t there? In other words, which ...
Heidelberg| New York, Feb. 8, 2017 -- Clint Alfaro is the winner of this year's ABC Best Paper Award, presented by the Springer journal Analytical and Bioanalytical Chemistry. In a paper published in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback